Suzhou Novoprotein Scientific Co. Ltd. A
Novoprotein Scientific Inc. researches, develops, produces, and sells raw materials and technical solutions for bio-pharmaceutical enterprises and research institutions in Asia, Europe, the United States, and Oceania. It offers cytokines, target proteins, mRNA vaccine and drug enzymes, recombinant antibodies, enzymes and reagents, biosimilar reference antibodies, gene and cell therapy, molecular … Read more
Market Cap & Net Worth: Suzhou Novoprotein Scientific Co. Ltd. A (688137)
Suzhou Novoprotein Scientific Co. Ltd. A (SHG:688137) has a market capitalization of $396.63 Million (CN¥2.91 Billion) as of March 19, 2026. Listed on the SHG stock exchange, this China-based company holds position #16593 globally and #4393 in its home market, demonstrating a 2.09% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Suzhou Novoprotein Scientific Co. Ltd. A's stock price CN¥41.47 by its total outstanding shares 70175439 (70.18 Million).
Suzhou Novoprotein Scientific Co. Ltd. A Market Cap History: 2022 to 2026
Suzhou Novoprotein Scientific Co. Ltd. A's market capitalization history from 2022 to 2026. Data shows change from $708.16 Million to $396.63 Million (-15.29% CAGR).
Suzhou Novoprotein Scientific Co. Ltd. A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Suzhou Novoprotein Scientific Co. Ltd. A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.49x
Suzhou Novoprotein Scientific Co. Ltd. A's market cap is 2.49 times its annual revenue
1740.90x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $708.16 Million | $264.55 Million | $90.72 Million | 2.68x | 7.81x |
| 2023 | $522.14 Million | $153.19 Million | $12.84 Million | 3.41x | 40.65x |
| 2024 | $317.53 Million | $127.56 Million | -$54.42 Million | 2.49x | N/A |
Competitor Companies of 688137 by Market Capitalization
Companies near Suzhou Novoprotein Scientific Co. Ltd. A in the global market cap rankings as of March 19, 2026.
Key companies related to Suzhou Novoprotein Scientific Co. Ltd. A by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #165 globally with a market cap of $114.33 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #285 globally with a market cap of $73.32 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #340 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #497 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $114.33 Billion | $451.59 |
| #285 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $73.32 Billion | $744.12 |
| #340 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #497 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Suzhou Novoprotein Scientific Co. Ltd. A Historical Marketcap From 2022 to 2026
Between 2022 and today, Suzhou Novoprotein Scientific Co. Ltd. A's market cap moved from $708.16 Million to $ 396.63 Million, with a yearly change of -15.29%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥396.63 Million | +3.55% |
| 2025 | CN¥383.05 Million | +20.63% |
| 2024 | CN¥317.53 Million | -39.19% |
| 2023 | CN¥522.14 Million | -26.27% |
| 2022 | CN¥708.16 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Suzhou Novoprotein Scientific Co. Ltd. A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $396.63 Million USD |
| MoneyControl | $396.63 Million USD |
| MarketWatch | $396.63 Million USD |
| marketcap.company | $396.63 Million USD |
| Reuters | $396.63 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.